Rising Biosciences, Inc. Launches TSW! Topicals (This S#*!t Works!), Delivering Innovative Pain Relief to Market in Q4...
September 29 2017 - 8:30AM
InvestorsHub NewsWire
Rising Biosciences, Inc.
Launches TSW! Topicals (This S#*!t Works!), Delivering Innovative
Pain Relief to Market in Q4; Unveils Scar Peptide
Serum
New York, NY September 29, 2017 Rising India's (OTC:
RSII) Rising Biosciences, Inc., a research
and development company focusing on oral and topical
pharmaceuticals with strict standards set forward by the
pharmaceutical compounding industry, announces today that it has
launched TSW Topicals (www.TSW-topicals.com), a range of
over-the-counter, topical pain relief products using an innovative
blend of clinically proven organic ingredients such as menthol,
curcumin, ginger and capsaicin to reduce inflammation and
effectively relieve pain.
Products include solutions for muscle and joint pain, back pain,
neuropathy/nerve pain and arthritis. TSW Pain, a topical pain
relief cream for muscle and joint relief, is currently under
testing to meet FDA requirements and Rising execs are confident it
will hit the market sometime during Q4.
The Company also announces today a trial run of its Clinical
Strength Peptide Serum for scar and skin repair. The serum produces
visible results with an effective ingredient base and delivery
system and Rising BioSciences is launching a sample run for a
limited number of subscribers to our newsletter. All you have to do
to reserve your sample is visit www.RisingBiosciences.com, scroll
to the bottom of the home page and 'Subscribe' to our newsletter
while supplies last.
"We have received an overwhelmingly positive response to its
trial run for TSW Pain and expect similar feedback for our clinical
strength peptide serum, states Doug Bowes, Director of Brand
Development.
As well, CEO Robert Weber has been working toward an official
name and ticker change for Rising India, Inc. and has retained the
services of the same attorney that assisted in successfully
attaining the name and symbol change for sister company, PAO Group,
Inc. (OTC: PAOG)
$RSII Clinical Strength Peptide Serum
$RSII Clinical Strength Peptide Serum Before and After
$RSII on Twitter for LIVE company updates!
www.twitter.com/risingindiausa
Forward-Looking Statements: Certain statements in this news
release may contain forward-looking information within the meaning
of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under
the Securities Exchange Act of 1934, and are subject to the safe
harbor created by those rules. All statements, other than
statements of fact, included in this release, including, without
limitation, statements regarding potential future plans and
objectives of the company, are forward-looking statements that
involve risks and uncertainties. There can be no assurance that
such statements will prove to be accurate and actual results and
future events could differ materially from those anticipated in
such statements. Technical complications, which may arise, could
prevent the prompt implementation of any strategically significant
plan(s) outlined above. The Company undertakes no duty to revise or
update any forward- looking statements to reflect events or
circumstances after the date of this release.
Rising Biosciences (CE) (USOTC:RBII)
Historical Stock Chart
From Aug 2024 to Sep 2024
Rising Biosciences (CE) (USOTC:RBII)
Historical Stock Chart
From Sep 2023 to Sep 2024